Miravant Pharmaceuticals, Inc.
Records under this name other than patents Miravant Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Miravant Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,521,551 | Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy Formerly held Lapsed on the fee record Ended Apr 21, 2021 · USPTO record | Lapsed on the fee record | Ended Apr 21, 2021 | USPTO record |
| US 6,462,192 | Processes for large scale production of tetrapyrroles Formerly held Term ended Term ended Apr 5, 2021 · USPTO record | Term ended | Term ended Apr 5, 2021 | USPTO record |
| US 6,605,606 | Solid forms of tin ethyl etiopurpurin and processes for producing such forms Formerly held Term ended Term ended Aug 4, 2020 · USPTO record | Term ended | Term ended Aug 4, 2020 | USPTO record |
| US 6,794,505 | Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy Formerly held Term ended Term ended Mar 30, 2020 · USPTO record | Term ended | Term ended Mar 30, 2020 | USPTO record |
| US 6,054,449 | Compounds and method for PDT of intimal hyperplasia and other diseases Formerly held Lapsed on the fee record Ended Apr 25, 2012 · USPTO record | Lapsed on the fee record | Ended Apr 25, 2012 | USPTO record |
| US 6,444,194 | Indium photosensitizers for PDT Lapsed on the fee record Ended Sep 3, 2010 · USPTO record | Lapsed on the fee record | Ended Sep 3, 2010 | USPTO record |
| US 6,906,050 | Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis Lapsed on the fee record Ended Jun 14, 2009 · USPTO record | Lapsed on the fee record | Ended Jun 14, 2009 | USPTO record |
| US 6,827,926 | Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy Lapsed on the fee record Ended Dec 7, 2008 · USPTO record | Lapsed on the fee record | Ended Dec 7, 2008 | USPTO record |
| US 6,376,483 | Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production Lapsed on the fee record Ended Apr 23, 2006 · USPTO record | Lapsed on the fee record | Ended Apr 23, 2006 | USPTO record |
| US 5,973,141 | Method for the demethoxycarbonylation of porphyrinic compounds such as pheophorbides Term ended Term ended no later than Oct 26, 2019 · Low confidence | Term ended | Term ended no later than Oct 26, 2019 | Low confidence |